GW Pharmaceuticals (GWP)


Latest News

Cancellation - GW Pharmaceuticals Plc

RNS Number: 8466Q AIM 05 December 2016 NOTICE 05/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM GW PHARMACEUTICALS PLC At the request of the company trading on AIM for the under-mentioned securities has been cancelled from 05/12/2016 7:00am ORDINARY SHARES OF 0.1P EACH, FULLY PAID (30544...

American Society of Epilepsy Annual Meeting

RNS Number: 7013Q GW Pharmaceuticals PLC 01 December 2016 GW Pharmaceuticals plc Announces Epidiolex (cannabidiol) Data Presentations and Educational Programs at the American Society of Epilepsy Annual Meeting - Presentations include clinical results from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet Syndrome, as well as additional ind...

GW Pharmaceuticals schedules FY results

GW Pharmaceuticals will announce its fourth quarter and year-end financial results for the period ending 30 September o...

Notice of Q4 and year-end results

RNS Number: 4818Q GW Pharmaceuticals PLC 30 November 2016 GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 London, UK, 30 Nov 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and comm...

All News

05-12-16Cancellation - GW Pharmaceuticals PlcRNS
01-12-16American Society of Epilepsy Annual MeetingRNS
30-11-16GW Pharmaceuticals schedules FY results StockMarketWire
30-11-16Notice of Q4 and year-end resultsRNS
24-11-16Holding(s) in CompanyRNS
22-11-16GW chief exec to present Piper Jaffray conferenceStockMarketWire
22-11-16Presenting at Piper Jaffray Healthcare ConferenceRNS
18-11-16Holding(s) in CompanyRNS
11-11-16Holding(s) in CompanyRNS
10-11-16Director Deals - GW Pharmaceuticals PLC (GWP)StockMarketWire
10-11-16Director/PDMR ShareholdingRNS
03-11-16Director/PDMR ShareholdingRNS
03-11-16Holding(s) in CompanyRNS
03-11-16Holding(s) in CompanyRNS
02-11-16Director/PDMR ShareholdingRNS
01-11-16Director/PDMR ShareholdingRNS
31-10-16Holding(s) in CompanyRNS
31-10-16Total Voting RightsRNS
31-10-16Holding(s) in CompanyRNS
28-10-16Director Stock Trading PlanRNS
28-10-16Director/PDMR ShareholdingRNS
26-10-16Director/PDMR ShareholdingRNS
25-10-16Director/PDMR ShareholdingRNS
21-10-16Posting of Shareholder CircularRNS
20-10-16Holding(s) in CompanyRNS
19-10-16GW to trade exclusively on NASDAQStockMarketWire
19-10-16Intention to Trade Exclusively on NASDAQRNS
07-10-16Director Stock Trading Plan - ReplacementRNS
06-10-16Director Stock Trading PlanRNS
30-09-16Total Voting RightsRNS
27-09-16Broker Forecast - Numis issues a broker note on GW Pharmaceuticals PLCStockMarketWire
26-09-16Second Positive Phase 3 Trial for Epidiolex in LGSRNS
14-09-16Director Deals - GW Pharmaceuticals PLC (GWP)StockMarketWire
14-09-16Director/PDMR ShareholdingRNS
07-09-16Presenting at Morgan Stanley Healthcare ConferenceRNS
31-08-16Total Issued Share CapitalRNS
26-08-16Broker Forecast - Numis issues a broker note on GW Pharmaceuticals PLCStockMarketWire
17-08-16Block listing Interim ReviewRNS
09-08-16Are GlaxoSmithKline plc and GW Pharmaceuticals plc simply too expensive?Motley Fool
09-08-16Notification of Future Change to BoardRNS

RSS feeds

  • Editorial news feed for LSE:GWP Editorial
  • Regulatory news feed for LSE:GWP Regulatory